DLA Piper acted as US counsel to Zealand Pharma on the offering.Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based medicines,…
Zealand Pharma’s US$1 Billion Equity Offering
DLA Piper acted as US counsel to Zealand Pharma on the offering.Zealand Pharma, a Danish biotechnology company focused on the discovery and development of peptide-based medicines,…